S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
Log in

Relevium Technologies News Headlines (CVE:RLV)

C$0.02
-0.01 (-20.00 %)
(As of 02/27/2020 10:27 AM ET)
Today's Range
C$0.02
Now: C$0.02
C$0.02
50-Day Range
C$0.02
MA: C$0.03
C$0.04
52-Week Range
C$0.02
Now: C$0.02
C$0.13
Volume8,000 shs
Average Volume286,593 shs
Market CapitalizationC$2.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Relevium Technologies (CVE RLV) News Headlines

Source:
DateHeadline
Wellness Company Anticipates Revenue Breakout In Early 2020Wellness Company Anticipates Revenue Breakout In Early 2020
www.baystreet.ca - February 7 at 7:59 AM
Relevium Announces Update Call for ShareholdersRelevium Announces Update Call for Shareholders
www.globenewswire.com - February 5 at 8:19 AM
Relevium’s CEO Provides an Open Shareholder Letter for 2020Relevium’s CEO Provides an Open Shareholder Letter for 2020
www.globenewswire.com - December 19 at 1:03 PM
Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing CompanyRelevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
finance.yahoo.com - November 8 at 8:01 PM
Relevium Acquires 100% of Late Stage Processing and Medical Sales Applicant WeedsenseRelevium Acquires 100% of Late Stage Processing and Medical Sales Applicant Weedsense
www.globenewswire.com - October 19 at 10:45 PM
Relevium Announces Results of Annual Meeting of Shareholders and Updates Other Regulatory MattersRelevium Announces Results of Annual Meeting of Shareholders and Updates Other Regulatory Matters
www.nasdaq.com - September 11 at 11:50 PM
Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD UpdateRelevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update
www.nasdaq.com - August 1 at 9:38 PM
Relevium Issues Statement Regarding Recent Promotional ActivityRelevium Issues Statement Regarding Recent Promotional Activity
finance.yahoo.com - July 2 at 10:49 AM
Relevium Closes Private Placement FinancingRelevium Closes Private Placement Financing
finance.yahoo.com - June 12 at 2:20 PM
Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales LicenseRelevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License
www.nasdaq.com - June 6 at 11:09 AM
Relevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and VisionRelevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and Vision
finance.yahoo.com - May 24 at 4:51 PM
Relevium Announces Private Share Purchase by CEORelevium Announces Private Share Purchase by CEO
www.nasdaq.com - May 22 at 10:49 AM
Relevium Technologies IncRelevium Technologies Inc
www.bloomberg.com - March 19 at 11:20 AM
Relevium Announces DTC Eligibility for the US MarketRelevium Announces DTC Eligibility for the US Market
globenewswire.com - February 8 at 4:39 PM
Relevium Announces Investor Web ConferenceRelevium Announces Investor Web Conference
globenewswire.com - January 29 at 10:46 AM
Relevium to Acquire Multi-Brand Company in the UKRelevium to Acquire Multi-Brand Company in the UK
feeds.benzinga.com - January 23 at 8:55 AM
Relevium To Host Screenings of Documentary “Weed The People” Across Canada Today -- CFN MediaRelevium To Host Screenings of Documentary “Weed The People” Across Canada Today -- CFN Media
globenewswire.com - January 15 at 4:28 PM
Relevium Announces the National Screening of “Weed the People” Movie Across Eight Major CitiesRelevium Announces the National Screening of “Weed the People” Movie Across Eight Major Cities
globenewswire.com - January 10 at 4:11 PM
Relevium Launches Its Leefylyfe™ Organically Sourced Whole Plant Hemp Derived CBD Products in the UKRelevium Launches Its Leefylyfe™ Organically Sourced Whole Plant Hemp Derived CBD Products in the UK
globenewswire.com - December 13 at 4:05 PM
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel